Cross-Market Thesis

Skin cancer vaccine gains FDA approval

This trader is expressing a view that Skin cancer vaccine FDA approved by December 31, 2027? are correlated outcomes, committing $1,610 to this thesis across 1 prediction market on Polymarket.

T
Trader_0x2128f69% win rate

Total

$1,610

Markets

1

Positions

  1. 1Skin cancer vaccine FDA approved by December 31, 2027?
    $1,610 @ 35¢
Skin cancer vaccine gains FDA approval — Cross-Market Analysis | PolySpotter